We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$27.7B
AUM Growth
+$1.67B
(+6.4%)
Cap. Flow
+$250M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
1,516
New
194
Increased
503
Reduced
567
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$579M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$371M |
| 3 |
Amazon
AMZN
|
+$367M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$235M |
| 5 |
ExxonMobil
XOM
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$442M |
| 2 |
Salesforce
CRM
|
+$407M |
| 3 |
T-Mobile US
TMUS
|
+$331M |
| 4 |
Home Depot
HD
|
+$283M |
| 5 |
PayPal
PYPL
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.21% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 12.48% |
| 4 | Communication Services | 9.55% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TSMC
TSM
$2.18T
| $198M | 0.72% |
2,663,175
+2,637,915
| +10,443% | +$191M |
|
27
PUT
MetLife
MET
$62.1B
| $195M | 0.7% |
2,690,000
+1,790,000
| +199% | +$128M |
|
28
McDonald's
MCD
$195B
| $188M | 0.68% |
711,749
+594,343
| +506% | +$157M |
|
|
29
PayPal
PYPL
$50.5B
| $173M | 0.63% |
2,434,861
-3,088,983
| -56% | -$247M |
|
30
United Therapeutics
UTHR
$23.1B
| $167M | 0.6% |
601,754
-11,530
| -2% | -$2.91M |
|
31
Merck
MRK
$318B
| $166M | 0.6% |
1,498,809
-1,148,321
| -43% | -$117M |
|
32
CALL
JPMorgan Chase
JPM
$950B
| $166M | 0.6% |
1,235,000
-55,000
| -4% | -$6.97M |
|
|
33
Pfizer
PFE
$153B
| $163M | 0.59% |
3,183,322
-9,217,842
| -74% | -$442M |
|
34
Marathon Petroleum
MPC
$83.7B
| $150M | 0.54% |
1,286,075
-354,546
| -22% | -$40.4M |
|
35
Biogen
BIIB
$30.7B
| $147M | 0.53% |
531,412
-71,804
| -12% | -$20.3M |
|
36
CVS Health
CVS
$122B
| $146M | 0.53% |
1,567,381
+712,595
| +83% | +$68.8M |
|
37
Workday
WDAY
$44.4B
| $136M | 0.49% |
813,570
+519,342
| +177% | +$81M |
|
38
CALL
Citigroup
C
$226B
| $135M | 0.49% |
2,980,000
-350,000
| -11% | -$15.9M |
|
|
39
PUT
T-Mobile US
TMUS
$190B
| $132M | 0.48% |
942,000
+742,000
| +371% | +$107M |
|
40
Zoetis
ZTS
$30B
| $131M | 0.47% |
896,569
+772,828
| +625% | +$114M |
|
41
Dollar Tree
DLTR
$25.2B
| $120M | 0.43% |
845,894
-563,786
| -40% | -$83.9M |
|
42
Thermo Fisher Scientific
TMO
$220B
| $119M | 0.43% |
215,556
+73,877
| +52% | +$39.1M |
|
43
Sherwin-Williams
SHW
$89.8B
| $118M | 0.43% |
497,406
+223,107
| +81% | +$51.6M |
|
44
Intel
INTC
$513B
| $117M | 0.42% |
4,421,889
+1,707,015
| +63% | +$47.4M |
|
|
45
PUT
Citigroup
C
$226B
| $115M | 0.42% |
2,545,000
-3,095,000
| -55% | -$141M |
|
46
Boston Scientific
BSX
$71.5B
| $114M | 0.41% |
2,466,741
-1,291,963
| -34% | -$55.9M |
|
47
Yum! Brands
YUM
$41.1B
| $112M | 0.4% |
876,193
+350,434
| +67% | +$42.4M |
|
48
Tesla
TSLA
$1.3T
| $112M | 0.4% |
910,119
+203,524
| +29% | +$38.5M |
|
49
NiSource
NI
$20.4B
| $110M | 0.4% |
4,023,162
+590,623
| +17% | +$15.5M |
|
50
CALL
Apple
AAPL
$4.57T
| $110M | 0.4% |
845,000
+15,000
| +2% | +$2.14M |
|
Similar funds
Assenagon Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Assenagon Asset Management held 1,516 positions worth $27.7B, up 6.4% from $26.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Assenagon Asset Management's Q4 2022 filing shows 194 new, 503 increased, 567 reduced and 174 closed positions. Its largest new stake was Autoliv: 905,829 shares worth $69.4M. The largest sale was Pfizer, an estimated $442M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Assenagon Asset Management's largest Q4 2022 buy was Autoliv: 905,829 shares worth $69.4M.
- Assenagon Asset Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $579M increase.
- Assenagon Asset Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $442M.
- Assenagon Asset Management fully exited PBF Energy in Q4 2022, selling an estimated $54.3M.
- Assenagon Asset Management's ten largest holdings make up 25% of its $27.7B portfolio in Q4 2022.
- Assenagon Asset Management opened 194 new positions and closed 174 in Q4 2022.
- Assenagon Asset Management's portfolio value rose 6.4% quarter-over-quarter to $27.7B.
Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.